7Baggers

BRF S.A
(NYSE:BRFS) 

BRFS stock logo

BRF S.A. focuses on raising, producing, and slaughtering poultry and pork for processing, production, and sale of fresh meat, processed products, pasta, margarine, and other products. The company's product portfolio comprises meat products, including frozen whole and cut chicken, frozen pork, and be...

Founded: 1934
Full Time Employees: 90,000
Sector: Consumer Defensive
Industry: Packaged Foods
Consumer Defensive
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-06-30 2025-06-06 2025-05-19 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2018-03-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-03-31 2014-12-31 
                                                 
      note
    		   12.31                                          
      net sales
    		13,561,117,000   13,239,707  35,875,584 22,711,655 10,867,663  35,532,958,000 23,288,016,000 11,997,860,000  33,484,167,000 21,333,844,000 10,071,859,000  34,618,863 19,522,706 9,291,389  22,716,953,000 7,063,409,000 7,449,045,000                      
      yoy
    		   21.83%  -99.90% -99.90% -99.91%  6.12% 9.16% 19.12%  96622.32% 109177.08% 108299.93%  -99.85% -99.72% -99.88%                          
      qoq
    		     57.96% 108.98%   52.58% 94.10%   56.95% 111.82%   77.33% 110.12%   221.61% -5.18%                       
      cost of sales
    		-9,924,566,000   -9,557,198  -27,473,542 -17,902,501 -8,645,982  -28,883,005,000 -19,239,866,000 -9,720,386,000  -29,098,084,000 -19,012,457,000 -9,358,029,000  -27,573,239 -15,670,856 -7,204,997  -18,633,112,000 -6,182,886,000 -5,828,909,000                      
      gross profit
    		3,636,551,000 19,690,670,000 2,371,064,000 3,682,509  8,402,042 4,809,154 2,221,681  6,649,953,000 4,048,150,000 2,277,474,000  4,386,083,000 2,321,387,000 713,830,000  7,045,624 3,851,850 2,086,392  4,083,841,000 880,523,000 1,620,136,000   -14,800     -8,300              
      yoy
    		 234255.77% 49203.14% 65.75%  -99.87% -99.88% -99.90%  51.61% 74.38% 219.05%  62152.58% 60166.81% 34113.61%  -99.83% -99.56% -99.87%   -5949579.73%                       
      qoq
    		-81.53% 730.46% 64287.19%   74.71% 116.46%   64.27% 77.75%   88.94% 225.20%   82.92% 84.62%   363.80% -45.65%                       
      gross margin %
    		26.82% Infinity% Infinity% 27.81% NaN% 23.42% 21.17% 20.44% NaN% 18.71% 17.38% 18.98% NaN% 13.10% 10.88% 7.09% NaN% 20.35% 19.73% 22.46% NaN% 17.98% 12.47% 21.75% NaN% NaN% -Infinity% NaN% NaN% NaN% NaN% -Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 
      operating income
    		                                             
      yoy
    		                                             
      qoq
    		                                             
      operating margin %
    		0% NaN% NaN% 0% NaN% 0% 0% 0% NaN% 0% 0% 0% NaN% 0% 0% 0% NaN% 0% 0% 0% NaN% 0% 0% 0% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 
      selling expenses
    		-1,826,302,000 -11,235,367,000  -1,644,804  -4,918,624 -3,176,085 -1,523,767  -4,772,201,000 -3,141,147,000 -1,584,564,000  -4,419,090,000 -2,715,788,000 -1,272,112,000  -4,624,899 -2,348,974 -1,103,976  -3,150,070,000 -1,057,781,000 -1,032,567,000                      
      general and administrative expenses
    		-179,285,000 -2,218,427,000  -111,063  -421,260 -304,738 -129,258  -310,779,000 -198,354,000 -95,086,000  -328,901,000 -203,497,000 -86,740,000  -573,966 -225,853 -98,680  -360,690,000 -122,609,000 -87,281,000                      
      impairment loss on trade receivables
    		3,237,000   -1,001  -13,258 -34,793 -15,920  -17,332,000 -7,392,000 -5,545,000  -7,274,000 -4,988,000 -3,397,000  -11,627 -5,716 -2,556  -6,850,000 22,024,000                       
      other operating income (expenses)
    		-121,278,000   -11,352  45,268 17,561 30,130  154,321,000 134,646,000 77,458,000  9,368,000 -12,779,000 -5,939,000  103,581 101,389 35,010  -82,861,000 147,221,000 -231,331,000                      
      income from associates and joint ventures
    		-148,388,000   -542,968  3,659,093 3,253,777 898,641  -2,264,087,000 -2,165,467,000 -1,023,781,000  -4,360,000 -644,546,000 -1,868,686,000   -694,847 976,726  7,192,215,000 2,086,260,000 3,987,252,000                      
      income before financial results and income taxes
    		1,364,535,000   1,371,321    1,481,507  -560,125,000 -1,329,564,000 -354,044,000  -364,174,000 -1,260,211,000 -2,523,044,000  1,938,713 677,849 1,892,916  7,675,585,000 1,955,638,000 4,225,107,000                      
      financial income
    		243,651,000 12,654,204,000 4,229,425,000 183,202  586,734 368,238 196,746  534,208,000 308,783,000 157,563,000  722,052,000 355,338,000 191,468,000  340,283 175,441 108,871  232,713,000 66,332,000 106,777,000                      
      financial expenses
    		-999,824,000 -18,186,363,000  -926,626  -2,886,451 -1,842,926 -931,482  -3,238,504,000 -2,210,821,000 -1,058,307,000  -2,655,907,000 -1,687,074,000 -810,994,000  -2,470,878 -1,477,049 -710,929  -1,942,389,000 -577,883,000 -614,740,000   12,900     -19,500              
      foreign exchange and monetary variations
    		334,537,000   698,950  -1,544,514 -1,519,444 -252,604  347,418,000 671,020,000 200,051,000  203,845,000 611,637,000 1,826,300,000  -216,381 418,139 -1,304,691  -5,396,236,000 -1,037,987,000 -3,813,529,000                      
      financial income (expenses)
    		-421,636,000   -44,474  -3,844,231 -2,994,132 -987,340  -2,356,878,000 -1,231,018,000 -700,693,000  -1,730,010,000 -720,099,000 1,206,774,000  -2,346,976 -883,469                           
      income before taxes
    		942,899,000   1,326,847   1,570,744 494,167  -2,917,003,000 -2,560,582,000 -1,054,737,000  -2,094,184,000 -1,980,310,000 -1,316,270,000  -408,263 -205,620 -13,833  569,673,000 406,100,000                       
      income taxes
    		-202,278,000   -202,412  -391,729 -77,999 10,826  137,062,000 167,655,000 20,718,000  -109,045,000 -100,349,000 -221,638,000  -38,818 27,206 38,275  -94,933,000 -102,230,000 50,464,000                      
      income for the period
    		740,621,000               -1,572,448,000  -494,883 -219,700 24,442  474,740,000 303,870,000                       
      income attributable to
    		                                             
      controlling shareholders
    		740,621,000   1,124,435  2,517,301 1,492,745 504,993  -2,779,941,000 -2,392,927,000 -1,034,019,000  -2,203,229,000 -2,080,659,000 -1,537,908,000  -454,014 -178,414 24,442  474,740,000 303,870,000 -45,921,000   114,900     202,300              
      non-controlling interest
    		 1,085,469,000                6,933                            
      income per share
    		                                             
      weighted-average shares outstanding - basic
    		                 808,013,781                            
      loss per share - basic
    		                                             
      weighted-average shares outstanding - diluted
    		                 808,013,781                            
      income per share - diluted
    		                 -0.56                            
      net sales revenue
    		 148,860,959,000 10,791,159,000                                           
      cost of products and goods sold
    		 -129,170,289,000                                            
      operating expenses
    		 -13,753,399,000                                            
      equity in earnings of subsidiaries
    		 -34,585,000 14,263,000                                           
      other operating income
    		 -265,020,000                                            
      net income before financial income
    		 5,937,271,000 1,435,552,000                                           
      net financial result
    		 -5,532,159,000                                            
      net income before taxes
    		 405,112,000                                            
      income and social contribution taxes
    		 2,391,309,000 2,822,691,000                                           
      current income and social contribution taxes
    		 -319,893,000 1,036,605,000                                           
      deferred income and social contribution taxes
    		 2,711,202,000 1,786,086,000                                           
      net profit for the year from continued operations
    		 2,796,421,000 1,710,635,000                                           
      net income for the year from discontinued operations
    		 1,084,449,000 1,084,766,000                                           
      net income for the year from continuing and discontinued operations
    		 3,880,870,000 2,795,401,000                                           
      net income attributable to:
    		                                             
      controlling interest – continuing operation
    		 1,710,635,000                                            
      controlling interest – discontinued operation
    		 1,084,766,000                                            
      controlling interest
    		 2,795,401,000 2,795,401,000                                           
      non-controlling interest – continuing operation
    		 1,085,786,000                                            
      non-controlling interest – discontinued operation
    		 -317,000                                            
      basic and diluted earnings per share – common continuing operation
    		 1.893                                            
      basic and diluted earnings per share – common discontinued operation
    		 1.201                                            
      basic and diluted earnings per share – common
    		 3.094                                            
      controlling interest - continuing operation
    		  1,710,635,000                                           
      controlling interest - discontinued operation
    		  1,084,766,000                                           
      non-controlling interest - continuing operation
    		                                             
      non-controlling interest - discontinued operation
    		                                             
      basic and diluted earnings per share - common continuing operation
    		  1.893                                           
      basic and diluted earnings per share - common discontinued operation
    		  1.201                                           
      basic and diluted earnings per share - common
    		  3.094                                           
      income for the year
    		   1,124,435   1,492,745 504,993                                      
      income (loss) before financial results and income taxes
    		     6,753,261 4,564,876                                       
      income (loss) before taxes
    		     2,909,030                                        
      income (loss) for the year
    		     2,517,301                                        
      income (loss) attributable to
    		                                             
      income (loss) per share
    		                                             
      weighted average shares outstanding - basic
    		                                             
      weighted average shares outstanding - diluted
    		                                             
      income (loss) per share - diluted
    		                                             
      continuing operations
    		                                             
      income from continuing operations
    		         -2,779,941,000 -2,392,927,000 -1,034,019,000  -2,203,229,000 -2,080,659,000 -1,537,908,000  -447,081 -178,414   474,740,000 303,870,000 -45,921,000                      
      income from discontinued operations
    		             -50,948,000 -50,948,000 -34,540,000  -47,802 -41,286                           
      loss for the period
    		         -2,779,941,000 -2,392,927,000 -1,034,019,000  -2,254,177,000 -2,131,607,000         -45,921,000                      
      net income from continuing operation attributable to
    		                                             
      net income from discontinued operations attributable to
    		                                             
      loss per share from continued operations
    		                                             
      loss per share - diluted
    		                                             
      loss per share from discontinued operations
    		                                             
      income per share from continued operations
    		                                             
      income per share - basic
    		                 -0.56                            
      losse per share - basic
    		                                             
      losse per share - diluted
    		                                             
      losses per share - basic
    		                 -0.06                            
      losses per share - diluted
    		                 -0.06                            
      losses per share from discontinued operations
    		                                             
      net income attributable to
    		                                             
      discontinued operations
    		                                             
      net income from discontinued operation attributable to
    		                                             
      income per share from continuing operations
    		                                             
      income (losses) per share from discontinued operations
    		                                             
      income (losses) per share - basic
    		                                             
      income (losses) per share - diluted
    		                                             
      impairment loss on trade and other receivables
    		                       -31,102,000                      
      income before taxes from continuing operations
    		                       -96,385,000                      
      losses per share from continuing operations
    		                                             
      net revenue
    		                          6,600     -800              
      cost of goods sold
    		                          12,000     1,400              
      operating revenues
    		                          7,200                   
      sales
    		                          19,200     -4,700              
      general and administrative
    		                          -31,400     -900              
      other operating expenses
    		                          -105,800     349,800              
      equity income
    		                          -21,000     -23,600              
      profit before financial result
    		                          -131,100     -59,400              
      financial revenues
    		                          5,500     -34,900              
      income before income tax and social contribution
    		                          100,900     323,800              
      current income tax and social contribution
    		                          -116,500     -110,800              
      deferred income tax and social contribution
    		                          61,500     121,000              
      descontinued operations
    		                                             
      net result of descontinued operations
    		                          118,700                   
      net income of the year
    		                          1,680,200     199,100              
      attributable to
    		                          306,400                   
      non-controlling shareholders
    		                          -97,100     429,700              
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-06-06 2023-09-30 2022-02-11 2021-09-30 2018-12-31 2017-12-31 2016-12-31 2016-03-31 2015-12-31 2014-07-03 
                
        current assets
      		          
        cash and cash equivalents
      		3,855,210,000  938  4,869,600 6,010,800,000 6,356,900,000 13.3 5,362,900,000  
        financial investments and marketable securities
      		16,121,532,000          
        trade accounts receivable
      		7,919,133,000    2,604,900 3,919,000,000 3,085,100,000 9.6 3,876,300,000  
        inventories
      		11,062,645,000  54,517  3,877,300 4,948,200,000 4,791,600,000 10 4,032,900,000  
        biological assets
      		3,724,163,000       3.3   
        recoverable taxes
      		3,801,014,000  27,748     3   
        prepaid expenses
      		644,435,000          
        notes receivable
      		34,280,000       0.8   
        advances to suppliers
      		419,009,000          
        derivative financial instruments
      		253,747,000          
        restricted cash
      		262,686,000       3.3   
        dividends receivable
      		1,169,000          
        other receivables
      		610,991,000          
        assets held for sale
      		1,343,629,000    3,326,300      
        total current assets
      		50,053,643,000    19,030,900 19,185,400,000 18,893,700,000 47.5 19,180,100,000  
        non-current assets
      		          
        judicial deposits
      		489,427,000       1.8   
        deferred income and social contribution taxes
      		5,108,406,000       3.1   
        investments
      		700,270,000          
        investment property
      		120,317,000          
        property, plant and equipment
      		40,427,521,000  139,042  10,697,000 12,190,600,000 11,746,200,000  10,915,800,000  
        right-of-use assets
      		4,775,229,000          
        intangible assets
      		19,671,286,000  206,553  5,019,400 7,197,600,000 6,672,600,000  5,010,900,000  
        total non-current assets
      		85,300,703,000    23,351,500 26,043,100,000 24,051,200,000 52.5 21,207,900,000  
        total assets
      		135,354,346,000    42,382,400 45,228,500,000 42,944,900,000 100 40,388,000,000  
        current liabilities
      		          
        trade accounts payable
      		20,897,879,000 5,778,000 55,919  5,552,400 6,445,500,000 5,839,800,000 11.7 4,745,000,000  
        accrued payroll and related charges
      		2,372,190,000          
        taxes payable
      		1,215,626,000  11,487        
        loans, financing and debentures
      		6,621,740,000          
        advances from customers
      		5,570,128,000          
        lease payable
      		1,246,651,000          
        notes payable
      		272,447,000          
        provision for contingencies
      		721,318,000          
        dividends and interest on equity paid
      		2,971,000          
        other payables
      		1,150,340,000          
        liabilities related to held-for-sale assets
      		847,228,000          
        total current liabilities
      		41,023,517,000    14,488,600 14,907,900,000 12,640,400,000 28.8 11,621,200,000  
        non-current liabilities
      		          
        total non-current liabilities
      		74,279,957,000    20,362,000 18,607,800,000 18,085,100,000 37 14,930,800,000  
        equity
      		          
        share capital
      		10,367,391,000          
        capital reserve and treasury shares
      		          
        legal reserve
      		624,664,000          
        tax incentive reserve
      		964,286,000          
        earnings reserve
      		2,637,330,000          
        other comprehensive income
      		          
        equity amounts related to assets held for sale
      		          
        retained earnings
      		88,132,000          
        controlling shareholders’ equity
      		2,816,466,000          
        non-controlling interest
      		17,234,406,000          
        total equity
      		20,050,872,000    7,531,800 11,712,900,000     
        total liabilities and equity
      		135,354,346,000    42,382,400 45,228,500,000     
        non derivative financial liabilities
      		          
        loans and borrowings
      		 3,948,651,000 22,688        
        principal
      		 2,839,213,000         
        interest
      		 1,109,438,000         
        supply chain finance
      		       2.9   
        lease liabilities
      		 515,998,000         
        derivative financial liabilities
      		          
        financial instruments designated as cash flow hedge
      		          
        interest rate derivatives
      		          
        currency derivatives
      		          
        commodities derivatives
      		          
        financial instruments not designated as cash flow hedge
      		          
        23.4.
      		          
        23.4.1.
      		          
        brf s.a. | condensed consolidated interim financial information – september 30, 2021
      		          
        table of contents
      		          
        09.30.21
      		 12,310         
        fair value hedge - derivative instruments
      		          
        interest rate swap
      		          
        corresponds to the accumulated amount of fair value hedge adjustments on the hedged items, included in the carrying amount of the debentures.
      		          
        23.4.2.
      		          
        i.
      		          
        other assets and liabilities
      		          
        exposure of assets and liabilities in foreign currencies
      		          
        exposure in result
      		          
        net p&l exposure
      		          
        argentinian peso
      		          
        angolan kwanza
      		          
        euros
      		          
        yen
      		          
        turkish liras
      		          
        u.s. dollars
      		          
        total
      		  523,866 -38,818,000       
        derivative instruments not designated
      		          
        non-deliverable forward
      		 265,000,000         
        futures - b3
      		 358,000,000         
        currency swap
      		 47,583,000         
        ii.
      		          
        cash flow hedge - derivative instruments
      		          
        collar
      		          
        cash flow hedge - non-derivative instruments
      		          
        bond brf sa brfsbz 5 7/8
      		          
        bond brf sa brfsbz 3.95
      		          
        corresponds to the effective portion of the hedge result accumulated in other comprehensive income.
      		          
        iii.
      		          
        net investment hedge - non-derivative instruments
      		          
        bond - brf sa brfsbz 4.35
      		 75,673,000         
        23.4.3.
      		          
        non-deliverable forward - buy
      		          
        collar - buy
      		          
        base price of each commodity in usd/ton, except for corn – b3 denominated in r/ton.
      		          
        non-deliverable forward - sell
      		          
        corn future - sell
      		          
        collar - sell
      		          
        put - buy
      		          
        23.5.
      		          
        income for the period
      		          
        jul - sep 2021
      		          
        net sales
      		          
        derivatives result
      		          
        net revenue
      		          
        cost of sales
      		          
        interests on loans and borrowings
      		          
        interest rate derivatives result
      		          
        foreign exchange variation on assets and liabilities
      		          
        foreign exchange derivatives result
      		          
        effects on financial result
      		          
        derivative instruments - current
      		          
        non-derivative instruments – current
      		          
        non-derivative instruments – non-current
      		          
        non-derivative instruments - non-current
      		          
        jan - sep 2021
      		          
        all effects are presented gross of taxes.
      		          
        statement of financial position
      		          
        designated derivatives
      		          
        not designated derivatives
      		          
        asset / (liability) net
      		          
        includes r(2,192) related to the time value of the foreign exchange option contracts, and r(234) related to the time value of the commodity options contracts.
      		          
        12.31.20
      		          
        assets
      		          
        designated as hedge accounting
      		          
        not designated as hedge accounting
      		          
        liabilities
      		          
        23.6.
      		          
        exchange rate - balance
      		          
        usd
      		          
        monetary assets and liabilities
      		          
        derivative instruments - not designated
      		          
        net effect
      		          
        eur
      		          
        jpy
      		          
        try
      		          
        aoa
      		          
        exchange rate - operating results
      		          
        revenue in usd
      		          
        ndf
      		          
        loans - designated
      		          
        operating results - commodities
      		          
        soy grain - cbot
      		          
        soybean meal - cbot
      		          
        soybean oil - cbot
      		          
        corn - cbot
      		          
        corn - b3
      		          
        put
      		          
        23.7.
      		          
        amortized cost
      		          
        cash and bank
      		          
        cash equivalents
      		          
        marketable securities
      		  29,824     1.8   
        derivatives not designated
      		          
        derivatives designated as hedge accounting
      		          
        written option– business combination
      		          
        all derivatives are classified at fair value through profit and loss. those designated as hedge accounting instruments have their gains and losses also affecting equity and inventories.
      		          
        the part of the loans and borrowings the is object in a fair value hedge is classified as fair value through profit and loss. the rest of the loans and borrowings balance is classified as amortized cost and those designated as cash flow or net investment hedge accounting instruments have their gains and losses also affecting equity.
      		          
        23.8.
      		          
        »
      		          
        level 1
      		          
        financial assets
      		          
        fair value through other comprehensive income
      		          
        stocks
      		 42,029,000         
        fair value through profit and loss
      		          
        savings account and overnight
      		 1,220,232,000         
        term deposits
      		 250,189,000         
        bank deposit certificates
      		          
        financial treasury bills
      		 312,515,000         
        investment funds
      		 21,371,000         
        derivatives
      		          
        financial liabilities
      		          
        976,007
      		 1,846,336,000         
        brf s.a.
      		          
        brf sa brfsbz 5 7/8
      		          
        brf sa brfsbz 4 3/4
      		          
        brf sa brfsbz 3.95
      		          
        brf sa brfsbz 2 3/4
      		          
        brf sa brfsbz 4 7/8
      		          
        brf sa brfsbz 5 3/4
      		          
        debenture - 1st issue
      		          
        debenture - 2nd issue
      		          
        debenture - 3rd issue
      		          
        brf gmbh
      		          
        brf sa brfsbz 4.35
      		          
        23.8.1.
      		          
        brf s.a. | 2022 and 2021 consolidated financial statements
      		          
        1.5.1.
      		          
        the fair value of the acquired assets and assumed liabilities in the business combination is presented below:
      		          
        mogiana group combined
      		          
        trade and other receivables
      		  59,758        
        other current and non-current assets
      		  5,486        
        lease liability
      		  10,168        
        payroll, related charges and employee profit sharing
      		  6,296        
        benefit from tax, civil and labor risks
      		  34,976        
        employee benefits
      		  2,081        
        deferred income taxes
      		  815        
        other current and non-current liabilities
      		  16,932        
        net assets acquired
      		  362,504        
        fair value of consideration transferred
      		  477,408        
        goodwill
      		  114,904        
        income before taxes - continued operations
      		   -408,263,000       
        nominal tax rate
      		   34,000       
        benefit (expense) at nominal rate
      		   138,809,000       
        adjustments to income taxes
      		          
        difference of tax rates on results of foreign subsidiaries
      		   26,062,000       
        difference of functional currency of foreign subsidiaries
      		   -25,589,000       
        deferred tax assets not recognized
      		   -792,387,000       
        share-based payment
      		   -18,215,000       
        penalties
      		   -7,012,000       
        investment grant
      		   59,454,000       
        adjustment to the expcted annual rate
      		   557,112,000       
        other permanent differences
      		   22,948,000       
        effective rate
      		   -9,500       
        current tax
      		   -310,621,000       
        deferred tax
      		   271,803,000       
        amount related to the non-recognition of deferred tax on tax losses carryforward in the amount of r2,330,550, due to limited capacity of realization (note 10.2).
      		          
        32
      		          
        33
      		          
        balance sheet data
      		          
        short-term debt
      		    4,547,400 5,031,400,000 3,245,000,000  2,628,200,000  
        long-term debt
      		    17,618,100 15,413,000,000 15,717,400,000 31.1 12,551,100,000  
        capital
      		    12,460,500 12,460,500,000 12,460,500,000  12,460,500,000  
        shareholders’ equity
      		          
        total shareholders' equity
      		      12,219,400,000 34.3 13,836,000,000  
        total liabilities and shareholders’ equity
      		      42,944,900,000  40,388,000,000  
        current
      		          
        interest on shareholders' equity receivable
      		       0.1   
        other financial assets
      		       0.3   
        other current assets
      		       1.9   
        19,147,601
      		       47.4   
        assets of discontinued operations and held for sale
      		       0.1   
        receivables from related parties
      		          
        other non-current assets
      		       0.5   
        investments inassociates and join ventures
      		       0.5   
        property, plan and equipment
      		       27   
        intangible
      		       12.4   
        balance sheets
      		          
        amounts in thousand of reais
      		          
        payroll and related charges
      		       1.2   
        tax payable
      		       0.9   
        interest on shareholders' equity
      		       1.3   
        employee and management profit saring
      		       0.7   
        other financial liabilities
      		       1.7   
        provision for tax, civil and labor risks
      		       0.6   
        pension and other post-employment plans
      		       0.2   
        other current liabilities
      		       1.1   
        11,621,113
      		       28.8   
        liabilities of discontinued operations
      		          
        other non-current liabilities
      		       2.4   
        shareholders' equity
      		          
        capital reserves
      		          
        income reserves
      		       15   
        treasury shares
      		       -9.8   
        other comprehensive loss
      		       -2.7   
        equity attributable to interest of controlling shareholde
      		       33.5   
        equity attributable to non-controlling interest
      		       0.8   
        total liabilities and shareholders' equity
      		       100   
        to support the fair value of assets acquired
      		          
        and liabilities assumed in determining the
      		          
        purchase price allocation, as follows:
      		          
        cash - consideration paid for
      		          
        acquisition of 40% of equity interest
      		          
        fair value of equity interest in akf
      		          
        immediately before acquisition of
      		          
        40% of equity interest
      		          
        transaction preliminary goodwill generated in
      		          
        allocation of relationship with
      		          
        customers
      		          
        deferred income tax
      		          
        goodwill in the acquisition of equity
      		          
        corresponding to assets (current and non-current) of
      		          
        r29.112 and liabilities (current and non-current) of
      		          
        r23.863.
      		          
        additionally, brf has a commitment to
      		          
        acquire the remaining equity interest of akf
      		          
        within 36 to 90 months from the acquisition
      		          
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-06-30 2025-05-19 2024-09-30 2024-06-30 2024-03-31 2021-12-31 
              
          cash flows from operating activities
        		      
          income for the period
        		1,865,056,000      
          adjustments for:
        		      
          depreciation and amortization
        		773,338,000 179,391,000 1,139,297 755,102 376,823  
          depreciation and depletion of biological assets
        		656,743,000  1,009,691 671,937 335,242  
          result on disposal of property, plant and equipments, investment and intangible
        		12,162,000      
          provision for tax, civil and labor risks
        		248,454,000  238,113 177,010 78,432  
          income from investments under the equity method
        		691,356,000  -3,658,951 -3,253,777 -898,641  
          financial results
        		466,110,000  3,844,231 2,994,132 987,340  
          deferred income tax
        		322,435,000  384,212 63,317 -10,623  
          short-term employee benefits
        		  345,005 274,597 87,188  
          other
        		224,658,000  -10,279 35,703 13,033  
          changes in assets and liabilities:
        		      
          trade accounts and notes receivables
        		2,507,389,000  1,376,981 -437,482 1,406,005  
          inventories
        		-349,220,000  -538,316 427,799 412,615  
          biological assets - current
        		-228,983,000  38,314 -9,218 -81,697  
          trade accounts payable
        		217,272,000  -2,821,433 -359,214 -957,735  
          cash generated by operating activities
        		7,406,770,000  3,831,313 2,816,305 2,235,260  
          redemptions (investments) in securities at fvtpl
        		1,285,000  271,212 8,987 5,839  
          interest received
        		235,674,000  424,894 146,045 83,426  
          dividends and interest on shareholders' equity received
        		  13 13   
          payment of tax, civil and labor provisions
        		-233,221,000  -203,291 -144,410 -76,904  
          derivative financial instruments
        		114,741,000 438,219,000 353 -74,644 -57,077  
          other operating assets and liabilities
        		-1,722,051,000  2,277,677 1,377,435 -689,052  
          net cash from operating activities
        		5,803,198,000  6,602,171 4,129,731 1,501,492  
          capital expenditures
        		-602,360,000  -424,845 -250,782 -120,860  
          free cash flows
        		5,200,838,000  6,177,326 3,878,949 1,380,632  
          cash flows from investing activities
        		      
          redemption (additions) on investments in securities at amortized cost
        		      
          (constitution) redemption of restricted cash
        		-8,665,000      
          investments in securities at fvtoci
        		-80,138,000  -922,937 -830,623   
          additions to property, plant and equipment
        		-602,360,000  -424,845 -250,782 -120,860  
          additions to biological assets - non-current
        		-724,734,000  -975,258 -651,662 -323,309  
          proceeds from disposals of property, plant, equipments and investment
        		9,822,000  74,486 58,433 29,933  
          additions to intangible
        		-124,688,000  -131,226 -106,748 -40,572  
          aquisição de participação em coligadas e joint ventures
        		2,922,000      
          capital increase in subsidiaries
        		-60,000,000  46,222 47,221 -10,000  
          net cash from investing activities
        		-1,587,841,000  -2,333,557 -1,734,161 -464,808  
          cash flows from financing activities
        		      
          proceeds from debt issuance
        		1,187,623,000  2,005,582 1,981,490 19,647  
          repayment of debt
        		-286,643,000  -3,594,406 -1,213,151 -404,307  
          payment of interest
        		-606,187,000  -1,238,429 -654,916 -461,358  
          payment of interest derivatives - fair value hedge
        		-66,428,000  -235,998 -153,452 -85,737  
          treasury shares acquisition
        		-416,741,000  -844,122 -348,272 -135,094  
          dividends and interests on shareholders' equity paid
        		      
          payment of lease liabilities
        		-320,217,000  -495,525 -325,196 -154,295  
          net cash from financing activities
        		-508,593,000  -4,402,898 -713,497   
          effect of exchange rate variation on cash and cash equivalents
        		1,191,000  -119,981 15,050 6,855 149,798,432 
          net increase in cash and cash equivalents
        		3,707,955,000  -254,265 1,697,123 -177,605  
          balance at the beginning at the period
        		3,989,024,000      
          balance at the end of the period
        		7,696,979,000  4,447,284 6,398,672 4,523,944  
          net income from continuing operations in the year
        		 1,710,635,000     
          non-cash items
        		      
          non-controlling interest
        		      
          provision for contingencies
        		 86,372,000     
          deferred taxes and tax liabilities
        		      
          equity in earnings of subsidiaries
        		      
          exchange variation on financing
        		 1,238,252,000     
          exchange variation on other assets and liabilities
        		      
          interest expenses on financial debt
        		 1,694,261,000     
          interest expenses on finance lease
        		 1,227,000     
          cost with issue of financial operations
        		 45,349,000     
          adjustment to present value and market-to-market
        		 100,000     
          estimated (reversion) losses on inventories
        		      
          estimated losses on doubtful accounts
        		 581,000     
          estimated losses on non-realization of recoverable taxes
        		 30,000,000     
          revaluation of investment property
        		      
          gain on fair value adjustment
        		      
          other non-cash effects
        		 17,955,000     
          equity changes
        		      
          trade accounts receivable
        		      
          judicial deposits and contingencies
        		      
          accrued payroll and related charges
        		 121,661,000     
          trade accounts payable and supplier chain financing
        		      
          current and deferred taxes
        		      
          notes receivable and payable
        		 3,165,208,000     
          other assets and liabilities
        		      
          cash flow from operating activities
        		 156,235,000     
          investments
        		      
          investments in fixed assets
        		      
          investments in non-current biological assets
        		      
          investments in intangible assets
        		      
          financial investments and marketable securities
        		      
          cash flow used in investing activities
        		      
          loans and financing
        		 600,919,000     
          loans obtained
        		 6,400,446,000     
          loans settled
        		      
          payment of derivatives - fair value hedge
        		      
          leases paid
        		 -5,394,000     
          treasury shares
        		      
          capital increase
        		      
          share issuance expenses
        		      
          dividends and interest on equity received
        		 194,303,000     
          cash flow from financing activities
        		 228,858,000     
          exchange variation on cash and equivalents
        		 489,021,000     
          discontinued operations net of cash
        		 3,693,234,000     
          cash flow in the year
        		      
          cash and cash equivalents
        		      
          balance at end of year
        		 732,320,000     
          balance at beginning of year
        		 1,940,237,000     
          change in the year
        		      
          income (loss) from continuing operations
        		  2,517,301    
          result on disposal of property, plant and equipments and intangible
        		  -32,853 -16,346 -17,715  
          redemption of restricted cash
        		  1    
          capital increase in affiliates
        		      
          capital increase through issuance of shares
        		      
          balance at the beginning of the period
        		  4,701,549 4,701,549 4,701,549  
          income from continuing operations
        		   1,492,745 504,993  
          benefit from contingencies
        		      
          cash flow provided by operating activities
        		      
          cash flow provided by financing activities
        		      
          net cash provided (used in) by financing activities
        		    -1,221,144  
          result on disposal of property, plant and equipments and investment
        		      
          write-down of inventories to net realizable value
        		      
          benefit from tax, civil and labor risks
        		      
          tax recoveries and gains in tax lawsuits
        		      
          gratuities for the employees
        		      
          other provisions
        		      
          additions to intangible assets
        		      
          business combination, net of cash
        		      
          operating activities
        		      
          investments in securities at fvtpl
        		      
          redemptions of securities at fvtpl
        		      
          investing activities
        		      
          additions on investments in securities at amortized cost
        		      
          redemptions of securities at amortized cost
        		      
          financing activities
        		      
          investments in securities at amortized cost
        		      
          employee profit sharing
        		      
          supply chain finance
        		      
          redemptions of securities at fvtoci
        		      
          sale of participation in subsidiaries with loss of control
        		      
          net cash from investing activities from discontinued operations
        		      
          acquisition of non-controlling interests
        		      
          net cash from operating activities⁽1⁾
        		      
          net cash invested in investing activities
        		      
          net cash from financing activities⁽1⁾
        		      
          net increase in the balance of cash and cash equivalents
        		      
          cash flow provided by operating activities before working capital
        		      
          payment of income taxes
        		      
          acquisition of participation in joint ventures and subsidiaries
        		      
          cash generated (applied) by operating activities
        		      
          capital increase in associates
        		      
          income
        		      
          impairment
        		      
          result on disposals of property, plant and equipments
        		      
          income from associates and joint ventures
        		      
          payment of income tax and social contribution
        		      
          net cash applied by operating activities from discontinued operations
        		      
          proceeds from disposals of property, plant, equipment and investments
        		      
          sale of participation in associated entities
        		      
          sale (acquisition) of participation in joint ventures and associated entities
        		      
          capital increase in associates and joint ventures
        		      
          advance for future capital increase
        		      
          net cash provided (used in) investing activities
        		      
          net cash provided (used in) investing activities from discontinued operations
        		      
          net cash provided (used in) by financing activities from discontinued operations
        		      
          at the beginning of the period
        		      
          at the end of the period
        		      
          cash (applied) generated by operating activities
        		      
          net cash (applied) provided by operating activities
        		      
          net cash (applied) provided by operating activities from discontinued operations
        		      
          redemption (investments) of restricted cash
        		      
          benefit from losses in inventories
        		      
          gains in tax lawsuit
        		      
          others
        		      
          redemption (investments) in restricted cash
        		      
          cash flow
        		      
          net cash from (used) in investing activities